Evidence map›Paper›PMID 33127860›Full record

ArticleRNA (New York, N.Y.)2021

PAR-TERRA is the main contributor to telomeric repeat-containing RNA transcripts in normal and cancer mouse cells.

Nikenza Viceconte, Axelle Loriot, Patrícia Lona Abreu, Marion Scheibe, Albert Fradera Sola, Falk Butter, Charles De Smet, Claus M Azzalin, Nausica Arnoult, Anabelle Decottignies

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Telomere Transcription inBiomedicines · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The makings of TERRA R-loops at chromosome ends.Cell cycle (Georgetown, Tex.) · 2021
    Review
  11. Article
  12. A Tale of Two States: Pluripotency Regulation of Telomeres.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Nikenza Viceconte *Genetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.ORCID 0000-0002-5101-4125
Axelle Loriot *Genetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.ORCID 0000-0002-5288-8561
Patrícia Lona AbreuInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Marion ScheibeQuantitative Proteomics, Institute of Molecular Biology (IMB), 55128 Mainz, Germany.ORCID 0000-0002-2181-2214
Albert Fradera SolaQuantitative Proteomics, Institute of Molecular Biology (IMB), 55128 Mainz, Germany.
Falk ButterQuantitative Proteomics, Institute of Molecular Biology (IMB), 55128 Mainz, Germany.ORCID 0000-0002-7197-7279
Charles De SmetGenetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.ORCID 0000-0002-4419-2812
Claus M AzzalinInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0002-9396-1980
Nausica ArnoultMCBD-University of Colorado Boulder, Boulder, Colorado 80309-0347, USA.ORCID 0000-0003-2633-0270
Anabelle DecottigniesGenetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.ORCID 0000-0001-7893-2527
de Duve Institute · BEInstitute of Molecular Biology · DEUniversity of Lisbon · PTUniversity of Colorado Boulder · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeric repeat-containing RNA (TERRA) molecules play important roles at telomeres, from heterochromatin regulation to telomerase activity control. In human cells, TERRA is transcribed from subtelomeric promoters located on most chromosome ends and associates with telomeres. The origin of mouse TERRA molecules is, however, unclear, as transcription from the pseudoautosomal PAR locus was recently suggested to account for the vast majority of TERRA in embryonic stem cells (ESC). Here, we confirm the production of TERRA from both the chromosome 18q telomere and the PAR locus in mouse embryonic fibroblasts, ESC, and various mouse cancer and immortalized cell lines, and we identify two novel sources of TERRA on mouse chromosome 2 and X. Using various approaches, we show that PAR-TERRA molecules account for the majority of TERRA transcripts, displaying an increase of two to four orders of magnitude compared to the telomeric 18q transcript. Finally, we present a SILAC-based pull-down screen revealing a large overlap between TERRA-interacting proteins in human and mouse cells, including PRC2 complex subunits, chromatin remodeling factors, DNA replication proteins, Aurora kinases, shelterin complex subunits, Bloom helicase, Coilin, and paraspeckle proteins. Hence, despite originating from distinct genomic regions, mouse and human TERRA are likely to play similar functions in cells.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptomeAnimalsAurora KinasesCell Line, TumorChromosomes, MammalianComputational BiologyFibroblastsGene Regulatory NetworksGranulocyte Precursor CellsHeLa CellsHumansMiceMonocytesMouse Embryonic Stem CellsNeoplasmsAurora KinasesBloom syndrome proteinNuclear Proteinsp80-coilinRecQ HelicasesRNA-Binding ProteinsRNA, MessengerShelterin ComplexTelomere-Binding ProteinsPARtelomeretelomeric RNATERRA interactome

Identifiers

PMID33127860
PMCPMC7749631
OpenAlexW3096447662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.